Nadia Cremonini

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Giorgio Treglia, Paola Castaldi, Maria Felicia Villani et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 156 citations

Medicine, Nuclear Medicine, Radiology +14

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

Cristina Romei, Stefano Mariotti, Laura Fugazzola et al. · European Journal of Endocrinology · 2010 · 133 citations · Full text

Medicine, Endocrinology, Genetics +17

Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study

Pierpaolo Trimboli, Nadia Cremonini, Luca Ceriani et al. · Clinical Endocrinology · 2013 · 98 citations

Medicine, Oncology, Radiology +17

Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients

Annibale Versari, Martina Sollini, Andrea Frasoldati et al. · Thyroid · 2013 · 89 citations

Medicine, Nuclear Medicine, Oncology +17

High-Sensitivity<i>BRAF</i>Mutation Analysis:<i>BRAF</i>V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas

Dario de Biase, V. Cesari, Michela Visani et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 72 citations · Full text

Medicine, Genetics, Oncology +17